| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |